🔎 Trials Near Me

Dachaigh › Cancer briste triple-negative › Nebraska › Omaha

Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an Omaha, NE

Tha 5 sgrùdaidhean airson Cancer briste triple-negative a’ lorg phàirtichean aig làraichean ann agus timcheall air Omaha (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • Nebraska Cancer Specialists, Omaha
  • XCancer, Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07189871

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

A’ fastadhÌre 1/2
  • University of Nebraska Medical Center, Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT06799065

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

A’ fastadhÌre 3
  • Oncology Hematology West - Methodist, Omaha
  • Nebraska Methodist Hospital (change from Chi Health Bergan Mercy), Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT05633654

CtDNA Based MRD Testing for NAC Monitoring in TNBC

A’ fastadhSgrùdadh amharc
  • Nebraska Methodist, Omaha
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 7 Faoi 2025 · NCT06230185

Sgrùdaidhean Cancer briste triple-negative ann am bailtean eile

Sgrùdaidhean eile ann an Omaha

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.